Related LncRNAs |
ID |
lncRNA Name |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
mutation |
Association identified by GWAS (rs1333040, C>T). |
18997786 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
locus |
We also confirmed prior associations near CDKN2A-CDKN2B locus. |
20364137 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
mutation |
Common disease genomewide association studies (GWAS) have surprisingly identified the ANRIL gene as a genetic susceptibility locus (rs3217992, A>G;rs1063192, C>T)shared associated by coronary disease, intracranial aneurysm and also type 2 diabetes. |
20956613 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
locus |
A genetic susceptibility locus. |
20956613 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
mutation |
Interestingly, genome wide association studies (GWAS) identified several variants in the intergenic region encompassing ANRIL to be associated with several diseases such as coronary heart disease, intracranial aneurysm, many type of cancers and T3D |
22928560 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
mutation |
Genetic variation in lncRNA genes causes disease and influences susceptibility |
23791884 |
LncRNADisease
|
EL0289 |
CDKN2B-AS1 |
intracranial aneurism |
N/A |
N/A |
N/A |
locus |
Furthermore, genome wide association studies have identified the ANRIL gene as a risk locus for coronary disease, intracranial aneurism, type 2 diabetes and several cancers including glioma. |
24624135 |
LncRNADisease
|
EL0482 |
ESRG |
intracranial aneurism |
N/A |
N/A |
N/A |
expression |
HESRG was expressed strongly and diffusively in the nuclei of tumor cells in intracranial germinoma and embryonal carcinoma as well as in human embryonic stem cells.In germinomas, 25 of 31 showed intensive (3+) expression, four cases showed moderate (2+) immunostaining and the remaining 2 cases showed weak (1+) immunostaining. |
21861197 |
LncRNADisease Lnc2Cancer
|
|